Pan Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Pan Gao has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Baoquan Xin
Department of Orthopaedic Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China
2 shared publications - Guangjian Bai
School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China
2 shared publications - Xing Huang
Department of Orthopedics, Shanghai Pudong Hospital, Pudong Medical Center, Fudan University, Shanghai, China
2 shared publications - Chenglong Yang
Orthopedic Oncology Center, Department of Orthopedics, Changzheng Hospital, Second Military Medical University, Shanghai, People’s Republic of China
1 shared publication - Tielong Liu
Shandong Second Medical University
1 shared publication - Tielong Liu
School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China
1 shared publication
Latest Publications
- Open Access
- 11 March 2026
- Published by Springer Nature in BMC Surgery
- Vol. 26 (1)
Surgical management and outcomes of spinal low-grade myofibroblastic sarcoma: a single-center case series and literature review
Low-grade myofibroblastic sarcoma (LGMS) is a rare fibroblastic/myofibroblastic malignancy, predominantly occurring in the head and neck and generally exhi
- 11 March 2026
- Published by Springer Nature in BMC Surgery
- Vol. 26 (1)
Open AccessSurgical management and outcomes of spinal low-grade myofibroblastic sarcoma: a single-center case series and literature review
Low-grade myofibroblastic sarcoma (LGMS) is a rare fibroblastic/myofibroblastic malignancy, predominantly occurring in the head and neck and generally exhi
- Open Access
- 15 December 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (50) , e36525
PRISMA-the 100 most-cited articles on chondrosarcoma recurrence: A bibliometric analysis
Background: Chondrosarcoma (CHS) is highly prone to recurrence and has become the most common malignant bone tumor in adults. The authors aim to identify and analyze the top 100 most-cited articles in this field, enabling researchers to quickly grasp the research focus and progress in the area of chondrosarcoma recurrence. Methods: A search in the Web of Science database yielded a total of 305 articles related to CHS recurrence between 2013 and 2022. Filtering was done based on the titles and abstracts of the articles in the list, and the top 100 most-cited articles were selected. The following information were analyzed using bibliometric methods: article title, first author, year of publication, journal of publication, total citations, country, institution, and keywords. Results: Among the selected 100 articles, the most frequently cited one has 224 citations. The most commonly appearing journals, institutions, and countries are as follows: “Clinical Orthopaedics Related Research” (5 times); Fudan University, University of Texas System, and Royal Orthopaedic Hospital (4 times each), with China and the USA cited the most (21 times each). The year 2018 is the most productive year (17 articles). About 97 first authors contributed one article each, and 3 had 2 articles each. Among all 229 keywords, the top 3 in frequency are CHS (20%), recurrence (4%), and surgery (3%). Twenty article topics are related to surgical treatment. Conclusion: Research on CHS recurrence is citation-rich but focuses more on treatments than understanding mechanisms, indicating a need for deeper mechanistic exploration for treatment breakthroughs in the future.
- 15 December 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (50) , e36525
Open AccessPRISMA-the 100 most-cited articles on chondrosarcoma recurrence: A bibliometric analysis
Background: Chondrosarcoma (CHS) is highly prone to recurrence and has become the most common malignant bone tumor in adults. The authors aim to identify and analyze the top 100 most-cited articles in this field, enabling researchers to quickly grasp the research focus and progress in the area of chondrosarcoma recurrence. Methods: A search in the Web of Science database yielded a total of 305 articles related to CHS recurrence between 2013 and 2022. Filtering was done based on the titles and abstracts of the articles in the list, and the top 100 most-cited articles were selected. The following information were analyzed using bibliometric methods: article title, first author, year of publication, journal of publication, total citations, country, institution, and keywords. Results: Among the selected 100 articles, the most frequently cited one has 224 citations. The most commonly appearing journals, institutions, and countries are as follows: “Clinical Orthopaedics Related Research” (5 times); Fudan University, University of Texas System, and Royal Orthopaedic Hospital (4 times each), with China and the USA cited the most (21 times each). The year 2018 is the most productive year (17 articles). About 97 first authors contributed one article each, and 3 had 2 articles each. Among all 229 keywords, the top 3 in frequency are CHS (20%), recurrence (4%), and surgery (3%). Twenty article topics are related to surgical treatment. Conclusion: Research on CHS recurrence is citation-rich but focuses more on treatments than understanding mechanisms, indicating a need for deeper mechanistic exploration for treatment breakthroughs in the future.